WBR253: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) Created page with "{{WBRQuestion |QuestionAuthor=Gerald Chi |ExamType=USMLE Step 1 |MainCategory=Biochemistry, Pathology |SubCategory=Musculoskeletal/Rheumatology |MainCategory=Biochemistry, Pat..." |
m refreshing WBR questions |
||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
{{WBRQuestion | {{WBRQuestion | ||
|QuestionAuthor=Gerald Chi | |QuestionAuthor=Gerald Chi (Reviewed by {{YD}}) | ||
|ExamType=USMLE Step 1 | |ExamType=USMLE Step 1 | ||
|MainCategory=Biochemistry, | |MainCategory=Biochemistry, Pathophysiology | ||
|SubCategory=Musculoskeletal/Rheumatology | |SubCategory=Musculoskeletal/Rheumatology | ||
|MainCategory=Biochemistry, | |MainCategory=Biochemistry, Pathophysiology | ||
|SubCategory=Musculoskeletal/Rheumatology | |SubCategory=Musculoskeletal/Rheumatology | ||
|MainCategory=Biochemistry, | |MainCategory=Biochemistry, Pathophysiology | ||
|SubCategory=Musculoskeletal/Rheumatology | |SubCategory=Musculoskeletal/Rheumatology | ||
|MainCategory=Biochemistry, | |MainCategory=Biochemistry, Pathophysiology | ||
|MainCategory=Biochemistry, | |MainCategory=Biochemistry, Pathophysiology | ||
|MainCategory=Biochemistry, Pathophysiology | |||
|SubCategory=Musculoskeletal/Rheumatology | |SubCategory=Musculoskeletal/Rheumatology | ||
|MainCategory=Biochemistry, | |MainCategory=Biochemistry, Pathophysiology | ||
|SubCategory=Musculoskeletal/Rheumatology | |SubCategory=Musculoskeletal/Rheumatology | ||
|MainCategory=Biochemistry, | |MainCategory=Biochemistry, Pathophysiology | ||
|SubCategory=Musculoskeletal/Rheumatology | |SubCategory=Musculoskeletal/Rheumatology | ||
|MainCategory=Biochemistry, | |MainCategory=Biochemistry, Pathophysiology | ||
|SubCategory=Musculoskeletal/Rheumatology | |SubCategory=Musculoskeletal/Rheumatology | ||
|MainCategory=Biochemistry, | |MainCategory=Biochemistry, Pathophysiology | ||
|MainCategory=Biochemistry, | |MainCategory=Biochemistry, Pathophysiology | ||
|SubCategory=Musculoskeletal/Rheumatology | |SubCategory=Musculoskeletal/Rheumatology | ||
|Prompt=A 37-year-old | |Prompt=A 37-year-old woman presents with malaise, proxmial muscle weakness, and swollen hand and knee joints. She also reports dry eyes and dry mouth. When exposed to cold temperatures, her fingers become pale and cyanotic and turn red and numb. Physical examination is remarkable for scaly erythematous eruptions overlying the knuckles and elbows. Laboratory findings demonstrate lymphopenia with mild anemia and thrombocytopenia. A diagnosis is then made following the detection of speckled anti-nuclear antibody as well as autoantibodies against extractable nuclear antigens. Which of the following structures is most likely to be the target of the antibodies? | ||
|Explanation=Mixed connective tissue disease (MCTD) combines features of scleroderma, myositis, systemic lupus erythematosus, and rheumatoid arthritis and is thus considered an overlap syndrome. MCTD commonly manifests with joint pain/swelling, malaise, Raynaud phenomenon, Sjögren's syndrome, muscle inflammation, and sclerodactyly. Distinguishing laboratory characteristics are a positive, speckled anti-nuclear antibody and an anti-U1-RNP antibody. | |||
|Explanation=Mixed connective tissue disease combines features of scleroderma, myositis, systemic lupus erythematosus, and rheumatoid arthritis and is thus considered an overlap syndrome. MCTD commonly | |||
|AnswerA=Transfer RNA (tRNA) | |AnswerA=Transfer RNA (tRNA) | ||
|AnswerAExp=Anti-U1-RNP antibody does not target tRNA. | |||
|AnswerAExp= | |AnswerB=Small interfering RNA (siRNA) | ||
|AnswerB=Small interfering RNA (siRNA) | |AnswerBExp=Anti-U1-RNP antibody does not target siRNA | ||
|AnswerBExp= | |||
|AnswerC=Small nuclear ribonucleoprotein (snRNP) | |AnswerC=Small nuclear ribonucleoprotein (snRNP) | ||
|AnswerCExp= | |AnswerCExp=Anti-U1-RNP antibody targets snRNP, which is a complex of snRNA (produced by RNAP II) and multiple proteins. | ||
|AnswerD=Heterogeneous nuclear RNA (hnRNA) | |AnswerD=Heterogeneous nuclear RNA (hnRNA) | ||
|AnswerDExp=Anti-U1-RNP antibody does not target hnRNA. The snRNP combines with hnRNA to form spliceosome and undergoes splicing. | |||
|AnswerDExp= | |||
|AnswerE=Deoxyribonucleic acid (DNA) | |AnswerE=Deoxyribonucleic acid (DNA) | ||
|AnswerEExp=Anti-U1-RNP antibody does not target DNA. | |||
|AnswerEExp= | |EducationalObjectives=Anti-U1-RNP antibodies are often elevated in patients with mixed connective tissue disease. Anti-U1-RNP antibody targets snRNP, which is a complex of snRNA (produced by RNAP II) and multiple proteins. | ||
|References=Ghirardello A, Doria A, Vesco P, et al. Blotting patterns of IgG anti-(U1)RNP antibodies in mixed connective tissue disease. Rheumatol Int. 1996;16(4):145-50.<br> | |||
First Aid 2015 page 213. | |||
|RightAnswer=C | |RightAnswer=C | ||
|Approved= | |WBRKeyword=Anti-U1-RNP antibody, Mixed connective tissue disease, MCTD, Small nuclear ribonucleoprotein | ||
|Approved=Yes | |||
}} | }} |
Latest revision as of 02:54, 28 October 2020
Author | [[PageAuthor::Gerald Chi (Reviewed by Yazan Daaboul, M.D.)]] |
---|---|
Exam Type | ExamType::USMLE Step 1 |
Main Category | MainCategory::Biochemistry, MainCategory::Pathophysiology |
Sub Category | SubCategory::Musculoskeletal/Rheumatology |
Prompt | [[Prompt::A 37-year-old woman presents with malaise, proxmial muscle weakness, and swollen hand and knee joints. She also reports dry eyes and dry mouth. When exposed to cold temperatures, her fingers become pale and cyanotic and turn red and numb. Physical examination is remarkable for scaly erythematous eruptions overlying the knuckles and elbows. Laboratory findings demonstrate lymphopenia with mild anemia and thrombocytopenia. A diagnosis is then made following the detection of speckled anti-nuclear antibody as well as autoantibodies against extractable nuclear antigens. Which of the following structures is most likely to be the target of the antibodies?]] |
Answer A | AnswerA::Transfer RNA (tRNA) |
Answer A Explanation | AnswerAExp::Anti-U1-RNP antibody does not target tRNA. |
Answer B | AnswerB::Small interfering RNA (siRNA) |
Answer B Explanation | AnswerBExp::Anti-U1-RNP antibody does not target siRNA |
Answer C | AnswerC::Small nuclear ribonucleoprotein (snRNP) |
Answer C Explanation | AnswerCExp::Anti-U1-RNP antibody targets snRNP, which is a complex of snRNA (produced by RNAP II) and multiple proteins. |
Answer D | AnswerD::Heterogeneous nuclear RNA (hnRNA) |
Answer D Explanation | AnswerDExp::Anti-U1-RNP antibody does not target hnRNA. The snRNP combines with hnRNA to form spliceosome and undergoes splicing. |
Answer E | AnswerE::Deoxyribonucleic acid (DNA) |
Answer E Explanation | AnswerEExp::Anti-U1-RNP antibody does not target DNA. |
Right Answer | RightAnswer::C |
Explanation | [[Explanation::Mixed connective tissue disease (MCTD) combines features of scleroderma, myositis, systemic lupus erythematosus, and rheumatoid arthritis and is thus considered an overlap syndrome. MCTD commonly manifests with joint pain/swelling, malaise, Raynaud phenomenon, Sjögren's syndrome, muscle inflammation, and sclerodactyly. Distinguishing laboratory characteristics are a positive, speckled anti-nuclear antibody and an anti-U1-RNP antibody. Educational Objective: Anti-U1-RNP antibodies are often elevated in patients with mixed connective tissue disease. Anti-U1-RNP antibody targets snRNP, which is a complex of snRNA (produced by RNAP II) and multiple proteins. |
Approved | Approved::Yes |
Keyword | WBRKeyword::Anti-U1-RNP antibody, WBRKeyword::Mixed connective tissue disease, WBRKeyword::MCTD, WBRKeyword::Small nuclear ribonucleoprotein |
Linked Question | Linked:: |
Order in Linked Questions | LinkedOrder:: |